Innovations in drug research: inhibitors of thromboxane and leukotrienes
- 1 May 1991
- journal article
- review article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 21 (s1) , 272-276
- https://doi.org/10.1111/j.1365-2222.1991.tb01741.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesisNature, 1990
- Identification and isolation of a membrane protein necessary for leukotriene productionNature, 1990
- Pharmacokinetic interaction between indomethacin and diflunisalEuropean Journal of Clinical Pharmacology, 1989
- L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitorCanadian Journal of Physiology and Pharmacology, 1989
- Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonistCanadian Journal of Physiology and Pharmacology, 1989
- Binding of protein kinase C to neutrophil membranes in the presence of Ca2+ and its activation by a Ca2+-requiring proteinase.Proceedings of the National Academy of Sciences, 1985